Clinical Trials Logo

Filter by:
NCT ID: NCT01743924 Completed - Bioavailability Clinical Trials

Bioavailability of Chemopreventive and Nutritional Compounds in Broccoli

Start date: July 2011
Phase: Phase 0
Study type: Interventional

The aim of this study was to determine the absorption of isothiocyanates (ITC) after ingestion of kailan-hybrid broccoli through the analysis of the correspondent urinary biomarkers. Furthermore, the effect of cooking (microwave) on the mentioned metabolic fate of these ITC was studied comparing to the uncooked vegetable.

NCT ID: NCT01743469 Completed - Clinical trials for Metastatic Renal Cell Cancer

A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers

Start date: December 2012
Phase: Phase 2
Study type: Interventional

This was an exploratory proof of concept study to determine the clinical activity of tasquinimod in patients with advanced or metastatic hepatocellular carcinoma, ovarian carcinoma, renal cell carcinoma and gastric carcinoma who had progressed after standard therapies.

NCT ID: NCT01743222 Completed - Clinical trials for Localized Adverse Reaction to Administration of Drug

Intralymphatic eASC Administration in Healthy Volunteers

Start date: January 2012
Phase: Phase 1
Study type: Interventional

The objective is to determine the safety, tolerability and feasibility of the inguinal intralymphatic administration of expanded allogeneic adipose-derived stem cells (eASCs)

NCT ID: NCT01743001 Completed - Clinical trials for Pulmonary Arterial Hypertension

Clinical Study to Evaluate the Effects of Macitentan on Exercise Capacity in Subjects With Eisenmenger Syndrome

MAESTRO
Start date: May 21, 2013
Phase: Phase 3
Study type: Interventional

Clinical study to assess the efficacy, safety, and tolerability of macitentan in subjects with Eisenmenger Syndrome.

NCT ID: NCT01742884 Completed - Clinical trials for Moderate Dry Eye Syndrome

Efficacy and Safety of a Treatment for Dry Eye Syndrome: Thealoz

Start date: December 2012
Phase: Phase 4
Study type: Interventional

The purpose of this study is to determine if Thealoz is effective in Dry Eye Syndrome exposed to controlled adverse environmental conditions.

NCT ID: NCT01742286 Completed - Clinical trials for ALK-activated Tumors

Phase I Study of LDK378 in Pediatric, Malignancies With a Genetic Alteration in Anaplastic Lymphoma Kinase (ALK)

Start date: August 28, 2013
Phase: Phase 1
Study type: Interventional

The purpose of this study was to estimate the maximum tolerated dose and/or recommended dose for expansion of LDK378 as a single agent, assess safety, tolerability and anti-tumor activity and characterize single and multiple-dose pharmacokinetics when administered orally to pediatric patients with ALK-activated tumors, with and without food.

NCT ID: NCT01742052 Completed - Clinical trials for Relapsing-remitting Multiple Sclerosis

Dose-finding Study of MT-1303

Start date: January 2013
Phase: Phase 2
Study type: Interventional

The primary objectives of the study are: - To evaluate the effects of three oral doses of MT-1303 compared to placebo given for a period of 24 weeks in subjects with relapsing-remitting multiple sclerosis (RRMS) on MRI parameters - To evaluate the safety and tolerability of three oral doses of MT-1303 compared to placebo given for a period of 24 weeks in subjects with RRMS.

NCT ID: NCT01742026 Completed - Infections Clinical Trials

Aspergillus PCR Early Detection in High Risk Oncohematological Patients

PCRAGA
Start date: February 2011
Phase:
Study type: Observational

ADVANCE THERAPY ASPERGILLOSIS INVASIVE BY PCR DETECTION

NCT ID: NCT01741922 Completed - Hypertension Clinical Trials

Effectiveness of Night Administration of Low Dose Aspirin in Hypertensive Patients

TAHPS
Start date: December 2012
Phase: Phase 3
Study type: Interventional

The goal is to investigate in patients with high blood pressure, BP, namely, those with systolic blood pressure and diastolic blood pressure, SBP/DBP higher than or equal to 140/90 mmHg, and high cardiovascular risk, under treatment with low-dose acetylsalicylic acid, ASA, whether changing the time they take the drug (same dose) to bedtime (from taking it at some point during the active part of the day) produces a drop in their blood pressure (mean systolic and diastolic over 24 hours) of at least 2.5 mm Hg; and also whether among non-dippers, under secondary treatment with low-dose ASA, there is be a greater decrease in their night BP when the drug is taken in the evening.

NCT ID: NCT01741545 Completed - Hepatitis C Virus Clinical Trials

Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia

MAGNITUDE
Start date: March 31, 2013
Phase: Phase 3
Study type: Interventional

The primary objective for this study is to evaluate the proportion of subjects who achieve SVR12 (HCV RNA < LLOQ (target not detected) at post-treatment follow-up Week 12 in subjects with Genotype(GT)-1b, -4 and GT-2, -3